Coya Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
COYA Company Description
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
COYA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view COYA Smart Score
Score Breakdown
COYA Company Description
Show More
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of COYA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by COYA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of COYA in WallStreetBets Daily Discussion
COYA News
Recent insights relating to COYA
CNBC Recommendations
Recent picks made for COYA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in COYA
Corporate Flights
Flights by private jets registered to COYA
Our Analysis